Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.49 USD | +1.77% | +4.15% | +11.87% |
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Analyst opinion has improved significantly over the past four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Property & Casualty Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.87% | 5.01B | - | ||
+54.21% | 68.15B | B- | ||
+12.21% | 50.45B | C+ | ||
+11.79% | 48.76B | B | ||
+17.92% | 43.56B | B- | ||
+35.41% | 37.61B | B- | ||
+69.69% | 31.77B | B | ||
+12.11% | 29.63B | B- | ||
+27.75% | 25.69B | C- | ||
+1.99% | 21.91B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSX Stock
- HCXLY Stock
- Ratings Hiscox Ltd